Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

What Happens with Small Dissections and Imperfections Only Shown by OCT?

When we carry out an angioplasty guided by angiography alone, as we historically have, we are almost blind. Nowadays, optical coherence tomography (OCT) offers plenty of detail but also raises costs, procedure time, and contrast volume. The question that this study aimed to answer is whether becoming aware of all small defects and imperfections in stent implantation, which are invisible to conventional angiography, is actually worth it. That is to say, the question was whether the impact of OCT-defined suboptimal stent implantation at long-term follow-up could be assessed.

stentSuch was the context for the Centro per la Lotta contro l’Infarto – Optimisation of Percutaneous Coronary Intervention (CLI-OPCI) registry, which compared the long-term outcome of angioplasty in 1211 patients from 13 independent OCT-experienced sites according to end-procedural OCT findings.

 

OCT assessment revealed suboptimal stent implantation in 30.9% (!) of lesions, which entails an increase in patients experiencing device-related events (52.8% vs. 28.0%, p <0,001).


Read also: OCT Follow-Up of Plaque Erosion with Medical Therapy and Without Stenting.


At a mean follow-up of 833 days, minimum lumen area <4.5 mm² (hazard ratio [HR]: 1.82; p < 0.001), distal stent edge dissection >200 µm (HR: 2.03; p = 0.004), and reference vessel plaque and lumen area <4.5 mm² at both the distal (HR: 5.22; p < 0.001) or proximal (HR: 5.67; p < 0.001) stent edges were independent predictors of stent failure.

 

Against all odds, other factors such as MLA/reference lumen area <70%, strut malapposition, and plaque protrusion or in-stent thrombus did not predict events.

 

Conclusion

Suboptimal stent implantation, defined according to specific OCT-defined criteria, predicts long-term events. However, other factors that were presumed predictors due to logical thinking and apparently supporting evidence were discarded as such. The quintessential example of this is probably acute stent malapposition.

 

Original title: Long-Term Consequences of Optical Coherence Tomography Findings During Percutaneous Coronary Intervention: The Centro Per La Lotta Contro L’infarto – Optimization Of Percutaneous Coronary Intervention (CLI-OPCI) LATE Study.

Reference: Francesco Prati et al. EuroIntervention 2018;14:e443-e451.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...